Oculis Hosts R&D Event to Share Pipeline Progress Today
Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...
Category : Healthcare and Pharmaceutical
Concept Life Sciences Expands SAB and Drug Discovery Capacity
Concept Life Sciences (CLS), a leading integrated drug discovery, development, and manufacturing organization backed by Limerston Capital, today announced key strategic appointments and advancements to...
Genenta Presents Strategic Vision at Biotech Forum in Qatar
Pierluigi Paracchi, CEO Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, will present at “Montalcini Global Biotech Tour” in Doha,...
HepaRegeniX Raises €21.5M to Advance Liver Drug HRX-215
HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today announced the second closing and completion of a €21.5...
Exicure Plans New Clinical Trial for Acute Myeloid Leukemia
Exicure, Inc. (Nasdaq: XCUR) today shared updates on its lead asset, GPC-100 (burixafor), a small molecule CXCR4 inhibitor. Exicure, Inc. (“Exicure”) is planning for a...
ImmunoPrecise AI Platform LENSai™ Aligns with FDA’s New Policy
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) a leader in AI-driven biotherapeutics, today announced its strong support for the U.S. Food and Drug Administration’s (FDA) recent decision to...
AdvanCell Announces $18M MRFF Funding for Prostate Cancer Therapy
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced $18M in Australian Federal Government Funding from the Medical Research Future Fund (MRFF) Frontiers...
Savara Announces New Employment Inducement Grant
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of inducement awards to seven new employees. On...
Nuclera Enhances eProtein Discovery for Membrane Protein Production
Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow...
Oxford Nanopore Expands Compatible Products Programme
Multiple new partnerships with approved products announced to support broader access to flexible, end-to-end sequencing applications. Oxford Nanopore Technologies today announced the expansion of its...